First Tracks Biotherapeutics Inc
TRAX
NASDAQ
Biotechnology
$44.04
USD
+0.01 (+0.02%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.54B
Volume 446.2K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2026 |
|---|---|
Revenue | 0.0 |
YoY Growth | — |
Cost of Revenue | 0.0 |
Gross Profit | 0.0 |
Selling, General & Administrative | 9.3 |
Other Operating Expenses | 0.0 |
Total Operating Expenses | 34.9 |
Operating Income | -34.9 |
EBITDA | -34.8 |
Other Income / Expense | -0.0 |
Total Other Income / Expense | 1.6 |
Income Before Income Taxes | -33.4 |
Income Taxes | 0.0 |
Net Income | -33.4 |
Consolidated Net Income / Loss | -33.4 |
Net Income Attributable to Common Shareholders | -33.4 |
Basic EPS | -$0.95 |
Diluted EPS | -$0.95 |
Basic Shares Outstanding | 35.0M |
Diluted Shares Outstanding | 35.0M |